Patents by Inventor Ephraim Brener

Ephraim Brener has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220211647
    Abstract: The present disclosure provides pharmaceutical compositions and methods for treating paracetamol amenable conditions, such as pain and fever. The pharmaceutical compositions comprise certain combinations of derivatives of 4-Aminophenols and N-acylethanolamines. Also disclosed are methods and kits for treating or minimizing paracetamol amenable conditions.
    Type: Application
    Filed: April 22, 2020
    Publication date: July 7, 2022
    Applicant: SCISPARC LTD.
    Inventors: Ascher SHMULEWITZ, Adi ZULOFF-SHANI, Ephraim BRENER
  • Publication number: 20220071949
    Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
    Type: Application
    Filed: November 12, 2021
    Publication date: March 10, 2022
    Applicant: SciSparc Ltd.
    Inventors: Ephraim Brener, Elran Haber, Ascher Shmulewitz
  • Publication number: 20220071948
    Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
    Type: Application
    Filed: November 12, 2021
    Publication date: March 10, 2022
    Applicant: SciSparc Ltd.
    Inventors: Ephraim Brener, Elran Haber, Ascher Shmulewitz
  • Patent number: 11234956
    Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
    Type: Grant
    Filed: April 19, 2016
    Date of Patent: February 1, 2022
    Assignee: SciSparc Ltd.
    Inventors: Ascher Shmulewitz, Elran Haber, Ephraim Brener
  • Publication number: 20220000833
    Abstract: The present disclosure provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines for treating obstructive sleep apnea (OSA). Also disclosed are methods and kits for treating the disease and minimizing OSA symptoms.
    Type: Application
    Filed: January 25, 2019
    Publication date: January 6, 2022
    Inventors: Adi ZULOFF-SHANI, Ephraim BRENER, Sscher SHMULEWITZ
  • Patent number: 11207290
    Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
    Type: Grant
    Filed: August 30, 2019
    Date of Patent: December 28, 2021
    Assignee: SciSparc Ltd.
    Inventors: Ephraim Brener, Elran Haber, Ascher Shmulewitz
  • Publication number: 20210393577
    Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
    Type: Application
    Filed: August 27, 2021
    Publication date: December 23, 2021
    Applicant: SciSparc Ltd.
    Inventors: Ascher SHMULEWITZ, Elran HABER, Ephraim BRENER
  • Patent number: 11197845
    Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
    Type: Grant
    Filed: October 10, 2019
    Date of Patent: December 14, 2021
    Assignee: SciSparc Ltd.
    Inventors: Ephraim Brener, Elran Haber, Ascher Shmulewitz
  • Publication number: 20210177779
    Abstract: The present invention provides pharmaceutical compositions comprising opioids and N-acylethanolamines, and methods for their use in preventing and treating a variety of opioid-responsive conditions and opioid-related side-effects.
    Type: Application
    Filed: November 27, 2020
    Publication date: June 17, 2021
    Applicant: SciSparc Ltd.
    Inventors: Ascher SHMULEWITZ, Elran HABER, Ephraim BRENER
  • Publication number: 20210093652
    Abstract: Disclosed herein are pharmaceutical compositions comprising at least one anti-bacterial and at least one cannabinoid and methods of use in treating or preventing bacterial infection or biofilm in a subject in need thereof.
    Type: Application
    Filed: June 9, 2020
    Publication date: April 1, 2021
    Applicant: THERAPIX BIOSCIENCES LTD.
    Inventors: Ephraim Brener, Elran Haber, Adi Zuloff-Shani, Ascher Shmulewitz
  • Publication number: 20200038367
    Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
    Type: Application
    Filed: October 10, 2019
    Publication date: February 6, 2020
    Applicant: THERAPIX BIOSCIENCES, LTD.
    Inventors: Ephraim Brener, Elran Haber, Ascher Shmulewitz
  • Publication number: 20200030281
    Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
    Type: Application
    Filed: October 1, 2019
    Publication date: January 30, 2020
    Applicant: THERAPIX BIOSCIENCES, LTD.
    Inventors: Ephraim Brener, Elran Haber, Ascher Shmulewitz
  • Publication number: 20200022946
    Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
    Type: Application
    Filed: August 30, 2019
    Publication date: January 23, 2020
    Applicant: THERAPIX BIOSCIENCES, LTD.
    Inventors: Ephraim Brener, Elran Haber, Ascher Shmulewitz
  • Publication number: 20190183914
    Abstract: Disclosed herein are pharmaceutical compositions comprising at least one anti-bacterial and at least one cannabinoid and methods of use in treating or preventing bacterial infection or biofilm in a subject in need thereof.
    Type: Application
    Filed: January 11, 2019
    Publication date: June 20, 2019
    Applicant: THERAPIX BIOSCIENCES LTD.
    Inventors: Ephraim Brener, Elran Haber, Adi Zuloff-Shani, Ascher Shmulewitz
  • Publication number: 20180116982
    Abstract: The present invention provides pharmaceutical compositions comprising opioids and N-acylethanolamines, and methods for their use in preventing and treating a variety of opioid-responsive conditions and opioid-related side-effects.
    Type: Application
    Filed: May 17, 2016
    Publication date: May 3, 2018
    Applicant: THERAPIX BIOSCIENCES LTD.
    Inventors: Ascher SHMULEWITZ, Elran HABER, Ephraim BRENER
  • Publication number: 20180078523
    Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
    Type: Application
    Filed: April 19, 2016
    Publication date: March 22, 2018
    Applicant: THERAPIX BIOSCIENCES LTD.
    Inventors: Ascher SHMULEWITZ, Elran HABER, Ephraim BRENER
  • Publication number: 20140227243
    Abstract: The present disclosure relates to compositions and methods for accelerating the healing process of wounds, increasing the closure of skin wounds, and decreasing inflammation at the site of a skin wound. Specifically, the disclosure relates to compositions comprising a delta-PKC activator, an alpha-PKC inhibitor, and a pharmaceutically acceptable carrier that is free of Ca2+ and Mg2+ cations. The disclosure also relates to compositions comprising an insulin or insulin analog and a pharmaceutically acceptable carrier that is free of Ca2+ and Mg2+ cations.
    Type: Application
    Filed: February 15, 2013
    Publication date: August 14, 2014
    Inventors: Liora BRAIMAN-WIKSMAN, Tamar TENNENBAUM, Inessa SOLOMONIK, Ofra LEVY-HACHAM, Ephraim BRENER
  • Publication number: 20130296224
    Abstract: The present disclosure provides a method, composition and kit for treatment of inflammatory disease and disorder using PKC isoform modulators. Exemplary modulators include inhibitors of PKC-alpha, PKC-epsilon and PKC-eta, as well as activators of PKC-delta.
    Type: Application
    Filed: January 23, 2013
    Publication date: November 7, 2013
    Inventors: Liora BRAIMAN-WIKSMAN, Tamar TENNENBAUM, Yuval SAGIV, Marina GARTSBEIN, Ephraim BRENER, Moshe BEN-HAMO, Liat HAMMER
  • Publication number: 20130274196
    Abstract: The present disclosure provides a method, composition and kit for treatment of inflammatory disease and disorder using PKC isoform modulators.
    Type: Application
    Filed: December 10, 2012
    Publication date: October 17, 2013
    Inventors: Liora BRAIMAN-WIKSMAN, Tamar TENNENBAUM, Yuval SAGIV, Marina GARTSBEIN, Ephraim BRENER, Moshe BEN-HAMO, Liat HAMMER
  • Patent number: 8349793
    Abstract: The present disclosure provides a method, composition and kit for treatment of inflammatory disease and disorder using PKC isoform modulators. Exemplary modulators include inhibitors of PKC-alpha, PKC-epsilon and PKC-eta, as well as activators of PKC-delta.
    Type: Grant
    Filed: July 13, 2011
    Date of Patent: January 8, 2013
    Assignee: Heal0r, Ltd.
    Inventors: Liora Braiman-Wiksman, Tamar Tennenbaum, Yuvai Sagiv, Marina Gartsbein, Ephraim Brener, Moshe Ben-Hamo, Liat Hammer